These data suggest that the loss of PEDF in cancer cells can have more profound effects in lipid flux due to a deficiency in the dual functions of PEDF as a pro-lipolytic protein as well as an inhibitor of DGAT1-mediated lipogenesis. The gene discussed is DGAT1; the disease is cancer.